Nu Skin Enterprises, Inc.
NUS
$6.55
-$0.08-1.21%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 241.45% | 209.28% | 206.20% | 167.92% | -1,063.13% |
| Total Depreciation and Amortization | -23.15% | -25.14% | -22.44% | -14.19% | -9.39% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -40.83% | -128.85% | -123.67% | -119.52% | -22.23% |
| Change in Net Operating Assets | -470.47% | -145.70% | -60.62% | -1.90% | 69.52% |
| Cash from Operations | -30.18% | -28.15% | -36.16% | -41.52% | -24.45% |
| Capital Expenditure | 19.77% | 17.57% | 26.90% | 34.00% | 27.66% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -100.00% | -- | -- | -- | -- |
| Other Investing Activities | 360.75% | 209.69% | -4.89% | 47.72% | -73.24% |
| Cash from Investing | -116.47% | 549.56% | 519.75% | 477.34% | 218.42% |
| Total Debt Issued | 1,766.67% | 266.67% | 266.67% | -- | -83.33% |
| Total Debt Repaid | -13.09% | -77.69% | -197.71% | -355.62% | -759.38% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -293.41% | -965.05% | -416.03% | 58.60% | 58.04% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 2.05% | 0.78% | 57.78% | 73.32% | 80.48% |
| Other Financing Activities | -83.64% | 157.46% | 147.16% | 119.25% | 76.22% |
| Cash from Financing | 78.88% | -51.98% | -107.19% | -92.14% | -1,083.44% |
| Foreign Exchange rate Adjustments | 120.08% | 132.76% | -221.18% | 188.58% | 70.29% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 41.61% | 174.81% | 532.07% | 453.05% | 49.67% |